Skip to main content
Have a personal or library account? Click to login
Metal ions, Alzheimer's disease and chelation therapy Cover

Metal ions, Alzheimer's disease and chelation therapy

Acta Pharmaceutica
Volume 61 (2011): Issue 1 (March 2011)
By:   
Open Access
|Mar 2011
References

References

  1. D. M. Skovronsky, V. M.-Y. Lee and J. Q. Trojanowski, Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications,(2006) 151-170; DOI: 10.1146/annurev.pathol.1.110304.100113.
    Open DOISearch in Google Scholar
  2. R. Mayeux, Epidemiology of neurodegeneration,(2003) 81-104; DOI: 10.1146/annurev.neuro.26.043002.094919.
    Open DOISearch in Google Scholar
  3. C. P. Ferri, R. Sousa, E. Albanese, W. S. Ribeiro and M. Honyashiki,(Eds. M. Prince and J. Jadeson), Alzheimer's Disease International, London 2009, pp. 1-22;
    Search in Google Scholar
  4. F. M. LaFerla and S. Oddo, Alzheimer's disease: Aβ, tau and synaptic dysfunction,(2005) 170-176; DOI: 10.1016/j.molmed.2005.02.009.
    Open DOISearch in Google Scholar
  5. M. Tolnay and A. Probst, Tau protein pathology in Alzheimer's disease and related disorders,(1999) 171-187; DOI: 10.1046/j.1365-2990.1999.00182.x.
    Open DOISearch in Google Scholar
  6. C. Ballatore, V. M.-Y. Lee and J. Q. Trojanowski, Tau-mediated neurodegeneration in Alzheimer's disease and related disorders,(2007) 663-672; DOI: 10.1038/nrn2194.
    Open DOISearch in Google Scholar
  7. C. W. Scott, A. Fieles, L. A. Sygowski and C. B. Caputo, Aggregation of tau protein by aluminum,(1993) 77-84; DOI: 10.1016/0006-8993(93)90940-O.
    Open DOISearch in Google Scholar
  8. A. Yamamoto, R.-W. Shin, K. Hasegawa, H. Naiki, H. Sato, F. Yoshimasu and T. Kitamoto, Iron (III) induces aggregation of hyperphosphorylated tau, and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease,(2003) 1137-1147; DOI: 10.1046/j.1471-4159.2002.01061.x.
    Open DOISearch in Google Scholar
  9. R.-W. Shin, T. P. A. Kruck, H. Murayama and T. Kitamoto, A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease,(2003) 139-146; DOI: 10.1016/S0006-8993(02)03893-3.
    Open DOISearch in Google Scholar
  10. T. Lührs, C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, H. Döbeli, D. Schubert and R. Riek, 3D structure of Alzheimer's amyloid-β (1-42) fibrils,(2005) 17342-17347; DOI: 10.1073/pnas.0506723102.
    Open DOISearch in Google Scholar
  11. W. P. Esler and M. S. Wolfe, A portrait of Alzheimer secretases - new features and familiar faces,(2001) 1449-1454; DOI: 10.1126/science.1064638.
    Open DOISearch in Google Scholar
  12. M. P. Mattson, Pathways towards and away from Alzheimer's disease,(2004) 631-639; DOI: 10.1038/nature02621.
    Open DOISearch in Google Scholar
  13. M. Shoji, T. Golde, J. Ghiso, T. Cheung, S. Estus, L. Shaffer, X. Cai, D. McKay, R. Tintner and B. Frangione, Production of the Alzheimer amyloid beta protein by normal proteolytic processing,(1992) 126-129; DOI: 10.1126/science.1439760.
    Open DOISearch in Google Scholar
  14. C. L. Masters, G. Simms, N. A. Weinman, G. Multhaup, B. L. McDonald and K. Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome,(1985) 4245-4249; DOI: 10.1073/pnas.82.12.4245.
    Open DOISearch in Google Scholar
  15. B. Clippingdale, J. D. Wade and C. J. Barrow, The amyloid-β peptide and its role in Alzheimer's disease,(2001) 227-249; DOI: 10.1002/psc.324.abs.
    Open DOISearch in Google Scholar
  16. C. Vigo-Pelfrey, D. Lee, P. Keim, I. Lieberburg and D. B. Schenk, Amyloid peptide from human cerebrospinal fluid,(1993) 1965-1968; DOI: 10.1111/j.1471-4159.1993.tb09841.x.
    Open DOISearch in Google Scholar
  17. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schiossmacher, J. Whaley, C. Swindlehurst, R. McCormack, R. Wolfert, D. Selkoe, I. Lieberburg and D. Schenk, Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids,(1992) 325-327; DOI: 10.1038/359325a0.
    Open DOISearch in Google Scholar
  18. J. T. Jarret, E. P. Berger and P. T. Lansbury, The C-terminus of the β protein is critical in amyloidogenesis,(1993) 144-148; DOI: 10.1111/j.1749-6632.1993.tb23043.x.
    Open DOISearch in Google Scholar
  19. A. Lorenzo and B. A. Yankner, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red,(1994) 12243-12247; DOI: 10.1073/pnas.91.25.12243.
    Open DOISearch in Google Scholar
  20. J. Hardy and D. J. Selkoe, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics,(2002) 353-356; DOI: 10.1126/science.1072994.
    Open DOISearch in Google Scholar
  21. H. Kozlowski, A. Janicka-Klos, J. Brasun, E. Gaggelli, D. Valensin and G. Valensin, Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation),(2009) 2665-2685; DOI: 10.1016/j.ccr.2009.05.011.
    Open DOISearch in Google Scholar
  22. Y. Hung, A. Bush and R. Cherny, Copper in the brain and Alzheimer's disease,(2010) 61-76; DOI: 10.1007/s00775-009-0600-y.
    Open DOISearch in Google Scholar
  23. P. J. Crouch, K. J. Barnham, A. I. Bush and A. R. White, Therapeutic Treatments for Alzheimer's disease based on metal bioavailability,(2006) 469-474; DOI: 10.1358/dnp.2006.19.8.1021492.
    Open DOISearch in Google Scholar
  24. M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell and W. R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques,(1998) 47-52; DOI: 10.1016/S0022-510X(98)00092-6.
    Open DOISearch in Google Scholar
  25. C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. E. Bacarra, D. M. Romano, M. A. Hartshorn, R. E. Tanzi and A. I. Bush, Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis,(1998) 12817-12826; DOI: 10.1074/jbc.273.21.12817.
    Open DOISearch in Google Scholar
  26. B. Raman, T. Ban, K.-I. Yamaguchi, M. Sakai, T. Kawai, H. Naiki and Y. Goto, Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid β peptide,(2005) 16157-16162; DOI: 10.1074/jbc.M500309200.
    Open DOISearch in Google Scholar
  27. P. Faller, Copper and zinc binding to amyloid-β: Coordination, dynamics, aggregation, reactivity and metal-ion transfer,(2009) 2837-2845; DOI: 10.1002/cbic.200900321.
    Open DOISearch in Google Scholar
  28. C. Hureau and P. Faller, A[beta]-mediated ROS production by Cu ions: Structural insights, mechanisms and relevance to Alzheimer's disease,(2009) 1212-1217; DOI: 10.1016/j.biochi.2009.03.013.
    Open DOISearch in Google Scholar
  29. M. A. Deibel, W. D. Ehmann and W. R. Markesbery, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress,(1996) 137-142; DOI: 10.1016/S0022-510X(96)00203-1.
    Open DOISearch in Google Scholar
  30. M. C. Boll, M. Alcaraz-Zubeldia, S. Montes and C. Rios, Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases,(2008) 1717-1723; DOI: 10.1007/s11064-008-9610-3.
    Open DOISearch in Google Scholar
  31. I. Maurer, S. Zierz and H. J. Moller, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients,(2000) 455-462; DOI: 10.1016/S0197-4580(00) 00112-3.
    Search in Google Scholar
  32. Q. Ma, Y. Li, J. Du, H. Liu, K. Kanazawa, T. Nemoto, H. Nakanishi and Y. Zhao, Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS,(2006) 841-849; DOI: 10.1016/j.peptides.2005.09.002.
    Open DOISearch in Google Scholar
  33. N. T. Watt, I. J. Whitehouse and N. M. Hooper, The role of zinc in Alzheimer's disease,(2011) in press; DOI: 10.4061/2011/971021.
    Open DOISearch in Google Scholar
  34. A. Bush, W. Pettingell, G. Multhaup, M. D. Paradis, J. Vonsattel, J. Gusella, K. Beyreuther, C. Masters and R. Tanzi, Rapid induction of Alzheimer A beta amyloid formation by zinc,(1994) 1464-1467; DOI: 10.1126/science.8073293.
    Open DOISearch in Google Scholar
  35. K. H. Lim, Y. K. Kim and Y.-T. Chang, Investigations of the molecular mechanism of metal-induced Aβ (1-40) amyloidogenesis,(2007) 13523-13532; DOI: 10.1021/bi701112z.
    Open DOISearch in Google Scholar
  36. C. Talmard, L. Guilloreau, Y. Coppel, H. Mazarguil, and P. Faller, Amyloid-beta peptide forms monomeric complexes with Cuand Znprior to aggregation,(2007) 163-165; DOI: 10.1002/cbic.200600319.
    Open DOISearch in Google Scholar
  37. M. P. Cuajungco and K. Y. Faget, Zinc takes the center stage: its paradoxical role in Alzheimer's disease,(2003) 44-56; DOI: 10.1016/S0165-0173(02)00219-9.
    Open DOISearch in Google Scholar
  38. Z.-Y. Mo, Y.-Z. Zhu, H.-L. Zhu, J.-B. Fan, J. Chen and Y. Liang, Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322,(2009) 34648-34657; DOI: 10.1074/jbc.M109.058883.
    Open DOISearch in Google Scholar
  39. P. W. Mantyh, J. R. Ghilardi, S. Rogers, E. DeMaster, C. J. Allen, E. R. Stimson and J. E. Maggio, Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide,(1993) 1171-1174; DOI: 10.1111/j.1471-4159.1993.tb03639.x.
    Open DOISearch in Google Scholar
  40. C. Opazo, X. Huang, R. A. Cherny, R. D. Moir, A. E. Roher, A. R. White, R. Cappai, C. L. Masters, R. E. Tanzi, N. C. Inestrosa and A. I. Bush, Metalloenzyme-like activity of Alzheimer's disease β-amyloid,(2002) 40302-40308; DOI: 10.1074/jbc.M206428200.
    Open DOISearch in Google Scholar
  41. D. G. Smith, R. Cappai and K. J. Barnham, The redox chemistry of the Alzheimer's disease amyloid beta peptide,(2007) 1976-1990; DOI: 10.2217/14796708.2.4.397.
    Open DOISearch in Google Scholar
  42. P. F. Good, D. P. Perl, L. M. Bierer and J. Schmeidler, Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study,(1992) 286-292; DOI: 10.1002/ana.410310310.
    Open DOISearch in Google Scholar
  43. I. Klatzo, H. Wisniewski and E. Streicher, Experimental production of neurofibrillary degeneration: 1. Light microscopic observations,(1965) 187-199; DOI: 10.1097/00005072-196504000-00002.
    Open DOISearch in Google Scholar
  44. R. D. Terry and C. Pena, Experimental production of neurofibrillary degeneration: 2. Electron microscopy, phosphatase histochemistry and electron prose analysis,(1965) 200-210; DOI: 10.1097/00005072-196504000-00003.
    Open DOISearch in Google Scholar
  45. D. Drago, M. Bettella, S. Bolognin, L. Cendron, J. Scancar, R. Milacic, F. Ricchelli, A. Casini, L. Messori, G. Tognon and P. Zatta, Potential pathogenic role of β-amyloid1-42-aluminum complex in Alzheimer's disease,(2008) 731-746; DOI: 10.1016/j.biocel.2007.10.014.
    Open DOISearch in Google Scholar
  46. A. Rauk, The chemistry of Alzheimer's disease,(2009) 2698-2715; DOI: 10.1039/b807980n.
    Open DOISearch in Google Scholar
  47. L. E. Scott and C. Orvig, Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease,(2009) 4885-4910; DOI: 10.1021/cr9000176.
    Open DOISearch in Google Scholar
  48. J. A. Duce and A. I. Bush, Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics,(2010) 1-18; DOI: 10.1016/j.pneurobio.2010.04.003.
    Open DOISearch in Google Scholar
  49. I. Bush and R. E. Tanzi, Therapeutics for Alzheimer's disease based on the metal hypothesis,(2008) 421-432; DOI: 10.1016/j.nurt.2008.05.001.
    Open DOISearch in Google Scholar
  50. A. Gaeta and R. C. Hider, The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy,(2005) 1041-1059; DOI: 10.1038/sj.bjp.0706416.
    Open DOISearch in Google Scholar
  51. P. Zatta, D. Drago, S. Bolognin and S. L. Sensi, Alzheimer's disease, metal ions and metal homeostatic therapy,(2009) 346-355; DOI: 10.1016/j.tips.2009.05.002.
    Open DOISearch in Google Scholar
  52. L. R. Perez and K. J. Franz, Minding metals: Tailoring multifunctional chelating agents for neurodegenerative disease,(2010) 2177-2187; DOI: 10.1039/b919237a.
    Open DOISearch in Google Scholar
  53. D. R. C. McLachlan, T. P. A. Kruck, W. Kalow, D. F. Andrews, A. J. Dalton, M. Y. Bell and W. L. Smith, Intramuscular desferrioxamine in patients with Alzheimer's disease,(1991) 1304-1308; DOI: 10.1016/0140-6736(91)92978-B.
    Open DOISearch in Google Scholar
  54. R. A. Cherny, J. T. Legg, C. A. McLean, D. P. Fairlie, X. Huang, C. S. Atwood, K. Beyreuther, R. E. Tanzi, C. L. Masters and A. I. Bush, Aqueous dissolution of Alzheimer's disease abeta amyloid deposits by biometal depletion,(1999) 23223-23228; DOI: 10.1074/jbc.274.33.23223.
    Open DOISearch in Google Scholar
  55. R. A. Cherny, K. J. Barnham, T. Lynch, I. Volitakis, Q.-X. Li, C. A. McLean, G. Multhaup, K. Beyreuther, R. E. Tanzi, C. L. Masters and A. I. Bush, Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease,(2000) 209-216; DOI: 10.1006/jsbi.2000.4285.
    Open DOISearch in Google Scholar
  56. C. Boldron, I. Van der Auwera, C. Deraeve, H. Gornitzka, S. Wera, M. Pitié, F. Van Leuven and B. Meunier, Preparation of cyclo-phen-type ligands: Chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases,(2005) 1976-1980; DOI: 10.1002/cbic.200500220.
    Open DOISearch in Google Scholar
  57. A. Dedeoglu, K. Cormier, S. Payton, K. A. Tseitlin, J. N. Kremsky, L. Lai, X. Li, R. D. Moir, R. E. Tanzi, A. I. Bush, N. W. Kowall, J. T. Rogers and X. Huang, Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis,(2004) 1641-1649; DOI: 10.1016/j.exger.2004.08.016.
    Open DOISearch in Google Scholar
  58. Z. Cui, P. R. Lockman, C. S. Atwood, C.-H. Hsu, A. Gupte, D. D. Allen and R. J. Mumper, Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases,(2005) 263-272; DOI: 10.1016/j.ejpb.2004.07.009.
    Open DOISearch in Google Scholar
  59. J.-Y. Lee, J. E. Friedman, I. Angel, A. Kozak and J.-Y. Koh, The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human [beta]-amyloid precursor protein transgenic mice,(2004) 1315-1321; DOI: 10.1016/j.neurobiolaging.2004.01.005.
    Open DOISearch in Google Scholar
  60. V. Moret, Y. Laras, N. Pietrancosta, C. Garino, G. Quelever, A. Rolland, B. Mallet, J. C. Norreel and J. L. Kraus, 1,1 '-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: A new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution,(2006) 3298-3301; DOI: 10.1016/j.bmcl.2006.03.026.
    Open DOISearch in Google Scholar
  61. H. Zheng, S. Gal, L. M. Weiner, O. Bar-Am, A. Warshawsky, M. Fridkin and M. B. H. Youdim, Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases:studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition,(2005) 68-78; DOI: 10.1111/j.1471-4159.2005.03340.x.
    Open DOISearch in Google Scholar
  62. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J. Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M. F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R. A. Cherny, A. I. Bush and J. K. Andersen, Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease,(2003) 899-909; DOI: 10.1016/S0896-6273 (03)00126-0.
    Search in Google Scholar
  63. R. A. Cherny, C. S. Atwood, M. E. Xilinas, D. N. Gray, W. D. Jones, C. A. McLean, K. J. Barnham, I. Volitakis, F. W. Fraser, Y.-S. Kim, X. Huang, L. E. Goldstein, R. D. Moir, J. T. Lim, K. Beyreuther, H. Zheng, R. E. Tanzi, C. L. Masters and A. I. Bush, Treatment with a copper-zinc chelator markedly and rapidly inhibits [beta]-amyloid accumulation in Alzheimer's disease transgenic mice,(2001) 665-676; DOI: 10.1016/S0896-6273(01)00317-8.
    Open DOISearch in Google Scholar
  64. H. Zheng, M. B. H. Youdim, L. M. Weiner and M. Fridkin, Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases,(2005) 190-203; DOI: 10.1111/j.1399-3011.2005.00289.x.
    Open DOISearch in Google Scholar
  65. C. Deraeve, M. Pitie, H. Mazarguil and B. Meunier, Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents,(2007) 193-195; DOI: 10.1039/b616085a.
    Open DOISearch in Google Scholar
  66. C. W. Ritchie, A. I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.-X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R. E. Tanzi and C. L. Masters, Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial,(2003) 1685-1691; DOI: 10.1001/archneur.60.12.1685.
    Open DOISearch in Google Scholar
  67. A. I. Bush, Metal complexing agents as therapies for Alzheimer's disease,(2002) 1031-1038. DOI: 10.1016/S0197-4580(02)00120-3.
    Open DOISearch in Google Scholar
  68. J. Tateishi, Subacute myelo-optico-neuropathy: Clioquinol intoxication in humans and animals,(Suppl.) S20-S24; DOI: 10.1046/j.1440-1789.2000.00296.x.
    Open DOISearch in Google Scholar
  69. M. S. Yassin, J. Ekblom, M. Xilinas, C. G. Gottfries and L. Oreland, Changes in uptake of vitamin B-12 and trace metals in brains of mice treated with clioquinol,(2000) 40-44; DOI: 10.1016/S0022-510X(99)00297-X.
    Open DOISearch in Google Scholar
  70. M. Di Vaira, C. Bazzicalupi, P. Orioli, L. Messori, B. Bruni and P. Zatta, Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: Structural characterization of its zinc(II) and copper(II) complexes,(2004) 3795-3797; DOI: 10.1021/ic0494051.
    Open DOISearch in Google Scholar
  71. C. C. Wagner, S. Calvo, M. H. Torre and E. J. Baran, Vibrational spectra of clioquinol and its Cu(II) complex,(2007) 373-376; DOI: 10.1002/jrs.1654.
    Open DOISearch in Google Scholar
  72. A. Budimir, N. Humbert, M. Elhabiri, I. Osinska, M. Birus and A.-M. Albrecht-Gary, Hydroxyquinoline based binders: Promising ligands for chelatotherapy?,, in press; DOI: 10.1016/j.jinorgbio.2010.08.014.
    Open DOISearch in Google Scholar
  73. R. A. Cherny, J. T. Legg, C. A. McLean, D. P. Fairlie, X. Huang, C. S. Atwood, K. Beyreuther, R. E. Tanzi, C. L. Masters and A. I. Bush, Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion,(1999) 23223-23228; DOI: 10.1074/jbc.274.33.23223.
    Open DOISearch in Google Scholar
  74. C. Grossi, S. Francese, A. Casini, M. C. Rosi, I. Luccarini, A. Fiorentini, C. Gabbiani, L. Messori, G. Moneti and F. Casamenti, Clioquinol decreases amyloid-β burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease,(2009) 423-440.
    Open DOISearch in Google Scholar
  75. L. Lannfelt, K. Blennow, H. Zetterberg, S. Batsman, D. Ames, J. Harrison, C. L. Masters, S. Targum, A. I. Bush, R. Murdoch, J. Wilson and C. W. Ritchie, Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial,(2008) 779-786; DOI: 10.1016/S1474-4422(08)70167-4.
    Open DOISearch in Google Scholar
  76. P. A. Adlard, R. A. Cherny, D. I. Finkelstein, E. Gautier, E. Robb, M. Cortes, I. Volitakis, X. Liu, J. P. Smith, K. Perez, K. Laughton, Q.-X. Li, S. A. Charman, J. A. Nicolazzo, S. Wilkins, K. Deleva, T. Lynch, G. Kok, C. W. Ritchie, R. E. Tanzi, R. Cappai, C. L. Masters, K. J. Barnham and A. I. Bush, Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ,(2008) 43-55; DOI: 10.1016/j.neuron.2008.06.018.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10007-011-0006-6 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian
Page range: 1 - 14
Published on: Mar 15, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
metal ions,
Alzheimer's disease,
neurodegeneration,
metal chelators,
chelation therapy
Related subjects:
Pharmacy,
Pharmacy, other

© 2011 Ana Budimir, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 61 (2011): Issue 1 (March 2011)
Next article